OncClubAll Oncology NewsPipeline Report
InsightsMedical World NewsOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsThe Talk
Conference CoverageConference Listing
Giants of Cancer CarePER EventsScientific InterchangesState of the Science Summit / IPCWebinars
Partners
Oncology Live®Oncology FellowsSupplements And Featured PublicationsAll Publications
CME/CE
Biomarker ConsortiumInteractive ToolsLearning ModulesPresentationsSponsored
Print SubscriptioneNewsletter
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
Spotlight -
  • REGISTER TODAY to explore data on a novel second-generation BTK inhibitor for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
  • Share your views with OncChats
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
    • Partners
    • CME/CE
Advertisement

News Network

March 6, 2019

March 6, 2019

March 9th 2019
February 27, 2019

February 27, 2019

March 1st 2019
February 20, 2019

February 20, 2019

February 25th 2019
February 13, 2019

February 13, 2019

February 17th 2019
Post-Conference Perspectives: Sequencing in the Current mCRC Paradigm

Post-Conference Perspectives: Sequencing in the Current mCRC Paradigm

February 8th 2019
February 6, 2019

February 6, 2019

February 8th 2019
January 30, 2019

January 30, 2019

February 3rd 2019
ASCO GI 2019: Post-Conference News on CRC

ASCO GI 2019: Post-Conference News on CRC

January 31st 2019
Post-Conference Perspectives: Peripheral T-Cell Lymphoma

Post-Conference Perspectives: Peripheral T-Cell Lymphoma

January 28th 2019
January 23, 2019

January 23, 2019

January 26th 2019
January 16, 2019

January 16, 2019

January 19th 2019
January 9, 2019

January 9, 2019

January 15th 2019
Post-Conference Perspectives: Breast Cancer Recurrence Score

Post-Conference Perspectives: Breast Cancer Recurrence Score

January 3rd 2019
Post-Conference Perspectives: Update on PARP Inhibitors in Breast Cancer

Post-Conference Perspectives: Update on PARP Inhibitors in Breast Cancer

December 28th 2018
December 19, 2018

December 19, 2018

December 27th 2018
Frontline Eltrombopag for Severe Aplastic Anemia

Frontline Eltrombopag for Severe Aplastic Anemia

December 26th 2018
December 12, 2018

December 12, 2018

December 17th 2018
ASH 2018 News

ASH 2018 News

December 1st 2018
November 28, 2018

November 28, 2018

December 1st 2018
November 14, 2018

November 14, 2018

November 19th 2018
Updates on Upfront Treatment of Metastatic Colorectal Cancer

Updates on Upfront Treatment of Metastatic Colorectal Cancer

November 16th 2018
November 7, 2018

November 7, 2018

November 13th 2018
ESMO 2018 News

ESMO 2018 News

October 21st 2018
The Changing Landscape of Treatment for EGFR+ Lung Cancer

The Changing Landscape of Treatment for EGFR+ Lung Cancer

October 20th 2018
October 10, 2018

October 10, 2018

October 16th 2018
Practical Application of Recent Clinical Data for Immunotherapy in NSCLC

Practical Application of Recent Clinical Data for Immunotherapy in NSCLC

October 10th 2018
October 3, 2018

October 3, 2018

October 6th 2018
September 26, 2018

September 26, 2018

September 27th 2018
September 18, 2018

September 18, 2018

September 22nd 2018
September 12, 2018

September 12, 2018

September 17th 2018
<1
...
34567891011
...
16>

Latest Conference Coverage

Isa-KRd Elicits MRD-Negative Remissions in Newly Diagnosed, High-Risk Myeloma

KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

Smoldering Multiple Myeloma Management Hinges on the Debate Between Treatment and Observation

Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact